Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | F10 | P00742 | 14/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5433231 | 0.87 | MAPT (0.47) | MAPTF10F2RAB9AALDH1A1 | |
| SCHEMBL5427885 | 0.86 | CYP1A2 (0.47) | MAPTCYP1A2CYP2D6CYP2C9F10 | |
| SCHEMBL5438701 | 0.85 | F10 (0.47) | MAPTCYP1A2CYP2D6CYP2C9F10 | |
| SCHEMBL5427267 | 0.82 | MAPT (0.51) | MAPTF10F2RAB9ANPC1 | |
| SCHEMBL5439007 | 0.82 | MAPT (0.50) | MAPTCYP1A2F10RAB9ANPC1 | |
| SCHEMBL5429249 | 0.81 | RAB9A (0.45) | MAPTCYP1A2CYP2D6CYP2C9F10 | |
| SCHEMBL5429198 | 0.81 | MAPT (0.47) | MAPTF10F2RAB9ANPC1 | |
| SCHEMBL5446487 | 0.78 | F10 (0.45) | MAPTCYP1A2CYP2D6CYP2C9F10 | |
| SCHEMBL5431735 | 0.77 | F10 (0.48) | MAPTCYP1A2CYP2D6CYP2C9F10 | |
| SCHEMBL5437923 | 0.76 | CYP1A2 (0.43) | MAPTCYP1A2CYP2D6CYP2C9F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070129361-A1 | LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | QIAO JENNIFER X | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129361-A1 | LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | PEPD, XPNPEP1, METAP1 | MAPT 4212/4885CYP1A2 2248/4885CYP2D6 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.